Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Completed 4Not yet recruiting 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Dermatologic 13Other hematologic neoplasm 8Myeloid 7CNS 4Lymphoid 2Genitourinary 2Gastrointestinal 2Tumor-Agnostic 1Sarcoma 1Other solid neoplasm 1Head & Neck 1Endocrine 1

Conditions

Neurofibromatosis 1 1Neurofibroma, Plexiform 1Neurofibroma 1Glioma 1Brain Neoplasms 1Astrocytoma 1

Interventions

Temozolomide 299Radiotherapy 219Bevacizumab 139Carboplatin 91Cyclophosphamide 88Etoposide 82Filgrastim 72Vincristine 69Irinotecan 69Magnetic Resonance Spectroscopy 65Cisplatin 59Radiation 58Radiosurgery 52Surgical Procedures, Operative 41Peripheral Blood Stem Cell Transplantation 40Topotecan 39Doxorubicin 39Lomustine 37Carmustine 36sargramostim 35Granulocyte Colony-Stimulating Factor 35Melphalan 34Nivolumab 32Chemotherapy, Adjuvant 32Radiotherapy, Intensity-Modulated 29Isotretinoin 29Everolimus 29Erlotinib Hydrochloride 27Thiotepa 25Vorinostat 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × peginterferon alfa-2b × CNS × Clear all
NCT00846430 2023-08-30

Medical Treatment of "High-Risk" Neurofibromas

Corewell Health West

Phase 2 Completed
9 enrolled 9 charts
CNS

Neurofibroma, Neurofibromatosis 1

NCT02343224 2022-01-24

Pegylated Interferon ALFA-2b in Children With Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas

Emory University

Phase 2 Completed
9 enrolled 12 charts
CNS

Astrocytoma

NCT00396019 2017-11-06

Study of PEG-Intron for Plexiform Neurofibromas

University of Pittsburgh

Phase 2 Completed
86 enrolled 6 charts
CNS

Neurofibroma, Plexiform

NCT00047879 2011-10-26

Phase II Trial of Peginterferon Alpha-2b and Thalidomide in Adults With Recurrent Gliomas

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
7 enrolled 8 charts
CNS

Brain Neoplasms, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡